What is OrbitalRX?
OrbitalRX is a technology firm dedicated to empowering pharmacy leaders by providing advanced tools for proactive drug supply management. The company's innovative platform is designed to dismantle data silos, consolidating all essential pharmacy data into a single, user-friendly interface. This aggregation of information is crucial for saving operational time and effectively mitigating the persistent impacts of medication shortages, a growing concern across the healthcare industry.
How much funding has OrbitalRX raised?
OrbitalRX has raised a total of $1.2M across 1 funding round:
Private Equity
$1.2M
Private Equity (2025): $1.2M, investors not publicly disclosed
What's next for OrbitalRX?
The substantial enterprise-level funding indicates OrbitalRX is poised for significant scaling and further development of its drug shortage management technology. This capital infusion will likely fuel expansion into new markets, enhance platform capabilities, and strengthen strategic partnerships. The company's focus on solving a critical industry pain point positions it for continued growth and influence in the health-tech landscape.
See full OrbitalRX company page
